BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37014074)

  • 1. Gene Supplementation in Mice Heterozygous for the D477G RPE65 Variant Implicated in Autosomal Dominant Retinitis Pigmentosa.
    Feathers KL; Jia L; Khan NW; Smith AJ; Ma JX; Ali RR; Thompson DA
    Hum Gene Ther; 2023 Jul; 34(13-14):639-648. PubMed ID: 37014074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice.
    Shin Y; Moiseyev G; Chakraborty D; Ma JX
    Am J Pathol; 2017 Mar; 187(3):517-527. PubMed ID: 28041994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.
    Choi EH; Suh S; Sander CL; Hernandez CJO; Bulman ER; Khadka N; Dong Z; Shi W; Palczewski K; Kiser PD
    Hum Mol Genet; 2018 Jul; 27(13):2225-2243. PubMed ID: 29659842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa.
    Kiang AS; Kenna PF; Humphries MM; Ozaki E; Koenekoop RK; Campbell M; Farrar GJ; Humphries P
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33261050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Light Has an Essential Effect on the Disease Expression in a Dominant RPE65 Mutation.
    Wu W; Takahashi Y; Ma X; Moiseyev G; Ma JX
    Adv Exp Med Biol; 2023; 1415():415-419. PubMed ID: 37440066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in
    Jauregui R; Cho A; Oh JK; Tanaka AJ; Sparrow JR; Tsang SH
    Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 32014860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.
    Li Y; Furhang R; Ray A; Duncan T; Soucy J; Mahdi R; Chaitankar V; Gieser L; Poliakov E; Qian H; Liu P; Dong L; Rogozin IB; Redmond TM
    Hum Mutat; 2019 Apr; 40(4):426-443. PubMed ID: 30628748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
    Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
    Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A).
    Ding Y; Carvalho E; Murphy C; McInerney V; Krawczyk J; O'Brien T; Howard L; Cai L; Shen S
    Stem Cell Res; 2020 Mar; 43():101665. PubMed ID: 31954326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy.
    Kenna PF; Humphries MM; Kiang AS; Brabet P; Guillou L; Ozaki E; Campbell M; Farrar GJ; Koenekoop R; Humphries P
    BMJ Open Ophthalmol; 2020; 5(1):e000462. PubMed ID: 32426524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa.
    Jauregui R; Park KS; Tsang SH
    Ophthalmic Genet; 2018 Aug; 39(4):544-549. PubMed ID: 29947567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation.
    Wu W; Takahashi Y; Shin HY; Ma X; Moiseyev G; Ma JX
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2115202119. PubMed ID: 35271391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of retinal disease-associated RPE65 mutations on retinoid isomerization.
    Bereta G; Kiser PD; Golczak M; Sun W; Heon E; Saperstein DA; Palczewski K
    Biochemistry; 2008 Sep; 47(37):9856-65. PubMed ID: 18722466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.
    Pennesi ME; Weleber RG; Yang P; Whitebirch C; Thean B; Flotte TR; Humphries M; Chegarnov E; Beasley KN; Stout JT; Chulay JD
    Hum Gene Ther; 2018 Dec; 29(12):1428-1437. PubMed ID: 29869534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPE65 c.353G>A, p.(Arg118Lys): A Novel Point Mutation Associated with Retinitis Pigmentosa and Macular Atrophy.
    Bjeloš M; Bušić M; Ćurić A; Šarić B; Bosnar D; Marković L; Kuzmanović Elabjer B; Rak B
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model of human RPE65 P25L hypomorph resembles wild type under normal light rearing but is fully resistant to acute light damage.
    Li Y; Yu S; Duncan T; Li Y; Liu P; Gene E; Cortes-Pena Y; Qian H; Dong L; Redmond TM
    Hum Mol Genet; 2015 Aug; 24(15):4417-28. PubMed ID: 25972377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
    Li S; Samardzija M; Yang Z; Grimm C; Jin M
    J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.